Sonida optimistic for near-term outcomes, with ‘significant momentum’ heading into Q4
By
Kimberly Bonvissuto
Oct 11, 2023
Third-quarter occupancy gains on the heels of finalization of a comprehensive restructuring plan are creating “significant momentum” and optimism for near-term outcomes for Sonida Senior Living heading...
Most seniors with RSV-linked hospitalization are aged ≥75
Oct 06, 2023
And patients aged ≥60 years hospitalized with RSV are more likely to have severe illness than those with COVID-19 or influenza.
Operators plan lower fee increases despite costs that remain elevated
By
Kimberly Bonvissuto
Oct 06, 2023
The high monthly resident fees introduced by senior living operators in the wake of the COVID-19 pandemic are starting to taper off, but that doesn’t mean costs are coming down, according to results...
Senior living poised to become ‘darling child’ of real estate, expert says
By
Kathleen Steele Gaivin
Oct 06, 2023
The senior living sector is poised for recovery over the next 12 to 18 months, according to Aron Will, CBRE’s vice chair and co-head of National Senior Housing Practice Capital Markets. In fact, he said,...
Severe SARS-CoV-2 appears to infect coronary vessels
Oct 05, 2023
SARS-CoV-2 targets plaque macrophages, and its entry is increased in cholesterol-loaded primary macrophages.
Service coordinator salaries present challenges for workers, providers, residents: report
By
Kimberly Bonvissuto
Oct 05, 2023
A new report finds that the average annual salary for full-time affordable housing service coordinators could make it difficult for providers to recruit new workers, could result in residents experiencing...
COVID-19 infection, vaccination have little effect on migraine worsening
Oct 04, 2023
An increased concern about migraine worsening was a risk factor for perceived migraine worsening.
FDA approves updated Novavax COVID-19 vaccine
Oct 04, 2023
The updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus.
Nirmatrelvir/ritonavir cuts COVID-19 complications in highest-risk patients
Oct 04, 2023
The risk for COVID-19 hospitalization or death was reduced for those who were severely or moderately immunocompromised.
In-hospital mortality evaluated for SARS-CoV-2-linked sepsis
Oct 04, 2023
March 2020 to November 2022 saw a decline in crude in-hospital mortality for SARS-CoV-2-linked sepsis from 33.4 to 14.9%.